Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression

Our findings demonstrate that resistance to ABT-414 arises through both adaptive transcriptional remodeling and newly acquired genetic alterations. TEK-mediated suppression of EGFR represents a previously unrecognized mechanism of resistance, with potential implications for overcoming antibody-drug conjugate failure in GBM.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2025-10-21
DOI
https://doi.org/10.1186/s12967-025-07216-5
Citations
2
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression

Kendra A. Porath, Jann Nagina Sarkaria, Nhan L. Tran, Fulvio D’Angelo et al.
2 citations
Journal of Translational Medicine
Glioma Diagnosis and Treatment
3.25
article

Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression

Kendra A. Porath, Jann Nagina Sarkaria, Nhan L. Tran, Fulvio D’Angelo, Dustin Grief, Teresa Noviello, Ritin Sharma, Shannon P. Fortin Ensign, Benjamin E. Rabichow, Mylan Blomquist, Jean Kloss, Krystine Garcia‐Mansfield, Antonella Paladino, Antonio Iavarone, Patrick Pirrotte, Michele Ceccarelli, Sonia Jain, Bianca M. Marin, Francesca Pia Caruso, Joseph C. Loftus, Christopher Sereduk
article en
2 citations

Abstract

Our findings demonstrate that resistance to ABT-414 arises through both adaptive transcriptional remodeling and newly acquired genetic alterations. TEK-mediated suppression of EGFR represents a previously unrecognized mechanism of resistance, with potential implications for overcoming antibody-drug conjugate failure in GBM.

Journal of Translational MedicineVol. 23(1)
Translational Genomics Research Institute (US), University of Miami (US), City of Hope (US), Biogem (IT), Mayo Clinic in Arizona (US), Mayo Clinic Hospital (US), Institute of Biostructure and Bioimaging (IT), National Research Council (IT), Sylvester Comprehensive Cancer Center (US), Neurological Surgery (US)
Openalex Percentile: Top 7%
Glioma Diagnosis and Treatment
3.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.